保妇康凝胶联合诺氟沙星治疗宫颈糜烂50例疗效观察

目的：探讨保妇康凝胶联合诺氟沙星治疗宫颈糜烂的临床效果。方法将100例宫颈糜烂患者根据随机数字表法分为观察组和对照组各50例。观察组给予保妇康凝胶和诺氟沙星联合治疗，对照组单独给予治糜灵栓治疗，比较两组患者临床症状的变化，并对临床疗效进行评价。结果观察组治愈率为86.00%，明显高于对照组的74.00%，临床症状评分改善较对照组明显，且其临床症状消失的时间短于对照组，差异均有统计学意义(P<0.05)。结论保妇康凝胶与诺氟沙星合用比治糜灵栓治疗宫颈糜烂效果更佳，且治愈时间上明显较优，值得临床上推广应用。     

复合树脂充填物与酸蚀牙齿间密合度的扫描电镜观察

用SEM观察6种复合树脂充填物与酸蚀牙齿间密合度。结果表明6种复合树脂充填物与牙齿间均有微缝隙,其宽度多数在5μm内,最宽为10～15μm。1月后再观察,清晰见到从酸蚀牙本质小管曳出的树脂突,其曳出方向与缝隙形成可能有关。     

Zero-Order Release Formulation of Oxprenolol Hydrochloride with Swelling and Erosion Control

Zero-order release of oxprenolol hydrochloride was obtained by controlling the swelling and erosion of the matrix. This formulation involves only mixing of drug, hydroxypropylmethylcellulose (HPMC), and sodium carboxymethylcellulose (Na CMC) at the ratio of 1:0.4:1.6, respectively, and compressing the mixture directly into tablets. The in vitro release pattern from this optimized matrix tablet was reproducible. Accelerated stability studies revealed that the optimized formulation remains stable for an approximately 2-year shelf life. This sustained-release (SR) tablet was evaluated in dogs, and for comparison a conventional (CV) formulation was also given at the same dose level. Plasma oxprenolol levels were monitored by a sensitive and specific high-performance liquid chromatographic (HPLC) method. Significant differences in the pharmacokinetic parameters, i.e., lower C _max, higher values of t _max, MRT, AUC, and plasma concentration at 24 hr, and nearly constant plasma levels over 12 hr, indicated that the SR matrix tablet is superior to the CV rapid-releasing formulation. The in vitro release parameters and in vivo pharmacokinetics correlated well.     

武汉市3～5岁儿童牙齿酸蚀症的研究

目的：调查武汉市3～5岁儿童的酸蚀症流行状况；评价儿童饮用饮料和饮食习惯、口腔卫生习惯与酸蚀症的关系。方法：随机抽样武汉市4所幼儿园3～5岁儿童共500人。对所有儿童进行酸蚀症和龋齿发病情况的临床检查以及问卷调查，问卷内容包括：儿童每天消耗饮料或食物的频率，以及口腔健康行为。收集酸蚀症儿童和无酸蚀症儿童各20人，对其唾液pH值、流速和缓冲能力进行测定和比较。结果：武汉市3—5岁儿童酸蚀症的患病率为9．3％。儿童睡觉时含奶瓶、喝饮料的习惯与酸蚀症的发生呈正相关。酸蚀症儿童和对照组儿童唾液分析结果无显著性差异。结论：预防酸蚀症应该减少酸性食物及饮料的消费量及频率。     

改进微波幅射器探头治疗宫颈糜烂疗效观察

目的：探讨改进的微波辐射器探头治疗宫颈糜烂的疗效。方法：将微波辐射器探头由双直线形、双针形、单针形等点线状改进成为“单舌形”和“双舌形”两种弧形平面探头，用于治疗宫颈糜烂。分析1999-2002年450例宫颈糜烂治疗资料，其中300例经微波治疗(A组)，150例经C02—激光治疗(B组)，随访1—3个月。结果：两组治疗后3个月内A组治愈率明显高于B组(P＜0．005)，总有效率A组明显高于B组(P＜0．025)。两组术中、术后不良反应比较：术中宫颈创面出血A组明显低于B组(P＜0．005)，术中腹痛、脱痂期出血量、术后局部感染率方面两组相似。结论：所改进的微波辐射器探头治疗宫颈糜烂治愈率高，操作安全，术后并发症少，医患乐于接受。     

健康教育对宫颈糜烂妇女治疗依从性的研究

目的 探讨多种形式的健康教育对提高宫颈糜烂治疗依从性的作用。方法 将确诊为宫颈糜烂的120例患者随机分为研究组、对照组。均给予相应的治疗。研究组增加健康教育内容。两组患者同时观察复诊率、治愈率、对医疗服务的满意程度、疾病的认知情况。结果 研究组增加健康教育后，患者复诊率、治愈率、诊疗满意程度、疾病认知情况均较对照组高(P＜O．05)。结论 健康教育能提高宫颈糜烂患者的治疗依从性，获得较高的治愈率。     

CO2激光治疗宫颈糜烂2412例疗效观察

目的 探讨CO2激光治疗宫颈糜烂的疗效。方法 采用CO2激光输出功率20-40w，波长10．6μm，针对轻、中、重不同糜烂程度采用不同光束强度，光斑直径约0．3-0．5的连续波治疗宫颈糜烂2412例。结果 术后三个月复查，总有效率100％。结论 CO2激光治疗术简单、安全、疗效满意，适用于治疗I-Ⅲ0宫颈糜烂。     

A protease inhibitor attenuates gastric erosions and microcirculatory disturbance in the early period after thermal injury in rats

The effects of camostat mesilate, a synthetic serine protease inhibitor on gastric microcirculation and active oxygen species generated by leucocytes from the gastric and jugular veins in the early period after thermal injury were assessed. Male Wistar rats were anaesthetized and a 30% full skin-thickness dorsal burn was inflicted. Camostat mesilate (100 mg/kg) was dissolved in distilled water and administered orally to rats 40 min before thermal injury (the camostat group). The control animals (the vehicle group) were administered distilled water orally. Rolling leucocytes as well as Monastral blue B deposits in venules were observed using in vivo microscopy. Active oxygen species were measured by chemiluminescence. Camostat mesilate decreased the total length of gastric erosion, venular deposits of Monastral blue B, and rolling of leucocytes in venules, and relatively increased luminol-dependent chemiluminescence activity generated by zymosan-stimulated leucocytes 15 min after thermal injury. These results suggest that serine proteases are involved in the formation of gastric erosions and gastric microcirculatory disturbance in the early period after thermal injury.